268 related articles for article (PubMed ID: 11130252)
1. Medullary thyroid carcinoma (MTC)--clinical and molecular aspects on the basis of own experience.
Pomorski L; Bartkowiak J; Pisarek H; Bartos M; Narebski J
Neoplasma; 2000; 47(5):323-6. PubMed ID: 11130252
[TBL] [Abstract][Full Text] [Related]
2. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
Skinner MA; Wells SA
Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
[TBL] [Abstract][Full Text] [Related]
3. Long term prognosis of medullary thyroid carcinoma in 39 patients.
Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
[TBL] [Abstract][Full Text] [Related]
4. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years.
Cupisti K; Wolf A; Raffel A; Schott M; Miersch D; Yang Q; Eisenberger CF; Röher HD; Knoefel WT
Ann Surg; 2007 Nov; 246(5):815-21. PubMed ID: 17968174
[TBL] [Abstract][Full Text] [Related]
6. [Decision making in postoperative incidentally found small C-cell-carcinoma].
Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT
Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440
[TBL] [Abstract][Full Text] [Related]
7. Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients.
Pelizzo MR; Boschin IM; Bernante P; Toniato A; Piotto A; Pagetta C; Nibale O; Rampin L; Muzzio PC; Rubello D
Eur J Surg Oncol; 2007 May; 33(4):493-7. PubMed ID: 17125960
[TBL] [Abstract][Full Text] [Related]
8. Long-term prognosis of medullary thyroid carcinoma.
Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
[TBL] [Abstract][Full Text] [Related]
9. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
[TBL] [Abstract][Full Text] [Related]
10. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
11. Presymptomatic thyroidectomy in multiple endocrine neoplasia 2a.
Heizmann O; Haecker FM; Zumsteg U; Müller B; Oberholzer M; Oertli D
Eur J Surg Oncol; 2006 Feb; 32(1):98-102. PubMed ID: 16325365
[TBL] [Abstract][Full Text] [Related]
12. [Surgical procedure in children with medullary thyroid gland carcinoma with reference to multiple endocrine neoplasia type II].
Schäfer K; Senninger N; Roth H; Buhr HJ
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():202-4. PubMed ID: 9101831
[TBL] [Abstract][Full Text] [Related]
13. [Medullary carcinoma of the thyroid].
Francomano F; Cotellese R; Scipione P; Ricci A; D'Aulerio A; Ricciardi A; Orlandi N; Napolitano L
G Chir; 1996 Oct; 17(10):535-42. PubMed ID: 9044606
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of syndrome of multiple endocrine neoplasia type 2].
Kuznetsov NS; Bel'tsevich DG; Poliakova EIu; Vasil'ev EV; Nemtsova MV
Khirurgiia (Mosk); 2002; (2):4-9. PubMed ID: 12418313
[TBL] [Abstract][Full Text] [Related]
15. Pheochromocytoma and medullary thyroid carcinoma in a pregnant multiple endocrine neoplasia-2A patient.
Sarathi V; Bandgar TR; Menon PS; Shah NS
Gynecol Endocrinol; 2011 Aug; 27(8):533-5. PubMed ID: 20672905
[TBL] [Abstract][Full Text] [Related]
16. Should patients with medullary thyroid carcinoma undergo extensive lymph node (re)operation to improve long-term survival?
Brumsen C; Haak HR; Goslings BM; van de Velde CJ
Henry Ford Hosp Med J; 1992; 40(3-4):271-5. PubMed ID: 1483874
[TBL] [Abstract][Full Text] [Related]
17. [The clinical characteristics and therapy of multiple endocrine neoplasia type 2].
Xie Y; Li HZ; Rong S; Zhu Y
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1096-9. PubMed ID: 15498294
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor].
Amosenko FA; Brzhezovskiĭ VZh; Liubchenko LN; Shabanov MA; Kozlova VM; Vanushko VE; Kazubskaia TP; Gar'kavtseva RF; Kalinin VN
Genetika; 2003 Jun; 39(6):847-54. PubMed ID: 12884527
[TBL] [Abstract][Full Text] [Related]
20. Medullary thyroid carcinoma experienced at Kanazawa University Hospital.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ohtake S; Nakamura S; Ishizaki T
J Surg Oncol; 1996 Jan; 61(1):27-33. PubMed ID: 8544456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]